Gilead Sciences's most recent trend suggests a bearish bias. One trading opportunity on Gilead Sciences is a Bear Call Spread using a strike $110.00 short call and a strike $120.00 long call offers a potential 8.23% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $110.00 by expiration. The full premium credit of $0.76 would be kept by the premium seller. The risk of $9.24 would be incurred if the stock rose above the $120.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Gilead Sciences is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Gilead Sciences is bearish.
The RSI indicator is at 25.03 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
Gilead to Buy Knight Therapeutics' Priority Review Voucher
Thu, 20 Nov 2014 20:27:47 GMT
Ooh La La: France Negotiates a Steep Discount for Sovaldi From Gilead
Thu, 20 Nov 2014 18:48:52 GMT
France pegs Gilead hepatitis C drug at “lowest price in Europe”
Thu, 20 Nov 2014 13:20:34 GMT
Gilead Gains on Harvoni's EU Approval for HCV Treatment
Wed, 19 Nov 2014 21:57:56 GMT
How Much? Gilead Pays $125M For an FDA Priority Review Voucher
Wed, 19 Nov 2014 20:41:50 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook